Drugs / 8R-70CAR T cells
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07569263 | Jul 2026 → Dec 2029 expected | metastatic malignant neoplasm in the brain | University of Florida | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06946680 | Jul 2026 → Dec 2030 expected | diffuse intrinsic pontine glioma | University of Florida | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT05353530 | Jul 2023 → Dec 2027 expected | glioblastoma | University of Florida | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 8R-70CAR T cells | “Single dose of 8R-70CAR T cells administered IV” NCT07569263 ↗2“Single dose of 8R-70CAR T cells administered IV” NCT05353530 ↗ “Single dose of 8R-70CAR T cells administered IV” NCT06946680 ↗ |
| Modality | Cell therapy | “CAR T cell therapy” NCT05353530 ↗ |
| Route | Intravenous | “Single dose of 8R-70CAR T cells administered IV” NCT05353530 ↗ |
| Target | CD70 | “CD70 CAR T Cell Therapy” NCT05353530 ↗ |